The PREDICT LAA trial aimed to examine whether cardiac computed tomography- based FEops HEARTguide™ computational modelling would benefit clinical outcomes when planning for left atrial appendage (LAA) closure. In this touchCARDIO interview, we speak with Dr Ole De Backer (Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark) to discuss the PREDICT LAA trial and the next steps.
The abstract entitled ‘The Value of FEops HEARTguide™ Computational Modeling in the Planning of Percutaneous LAA Closure: The PREDICT LAA Trial’ was presented at the Transcatheter Cardiovascular Therapeutics (TCT) conference, 16 – 19, September 2022.
Questions:
- What were the aims, design and eligibility criteria of the PREDICT LAA Trial? (0:18)
- What were the primary and secondary endpoints and how well were they achieved? (1:26)
- What questions remain unanswered and what future studies are planned? (4:56)
Disclosures: Ole De Backer has nothing to disclose in relation to this video interview.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Danielle Crosby.
Filmed as a highlight of TCT 2022
Access more content on Atrial Fibrillation here and Interventional Cardiology here
